NESS-040C5 explained

NESS-040C5 is a potent cannabinoid agonist which was developed for the treatment of glaucoma.[1] It has reasonable selectivity for the CB2 receptor subtype, having a CB2 affinity of 0.4nM, and 25x selectivity over the related CB1 receptor.[2]

See also

Notes and References

  1. https://patents.google.com/patent/US8106218 Paolo Lazzari et al. Pharmaceutical Compounds. US Patent 8106218
  2. Hanus LO, Mechoulam R . Novel natural and synthetic ligands of the endocannabinoid system . Current Medicinal Chemistry . 2010 . 17 . 14 . 1341–59 . 20166928 . 10.2174/092986710790980096 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "NESS-040C5".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.